Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changed its name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is currently focusing on developing picoplatin, a new and differentiated platinum-based chemotherapeutic agent that is used in the clinical development for multiple cancer indications, treatment combinations, and by different routes of administration. The company was founded in 1984 and is headquartered in Seattle, WA.

Hefei Zhongkepu Ruisheng Biomedical Technology Co., Ltd., established on 2015-07-16, Business scope includes research on biomedical engineering technology,to develop,transfer,consultation service,Biomedical Experimental Technology Services,Experimental technology consulting service and transfer;Biological experiment reagent,Development of Consumables for Biological Experiments,Sales;Drug and medical information consultation service;Self-operated and agent import and export business of various commodities and technologies(Except for those restricted or prohibited by the state);clinical body fluid,blood test;Clinical tissue and cell biology assays,Molecular genetics professional testing;Medical testing consultation;Medical Information Consultation;data collection;Big Data Services and Applications;Research and development of biomedical technology and software technology,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

Manufactures pharmaceuticals

Scientic, Inc. provides systems engineering services. The firm specializes in scientific, engineering radiation survivability, test, prototyping and production. The company was founded in 2008 and is headquartered in Huntsville, AL.

GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway.

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

Beijing Ruiyiren Technology Development Co., Ltd., established on 2003-03-07, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;computer technology training;Basic software service;Application software service;Computer System Services;data processing;computer repair;selling computers,Software and Auxiliary Equipment,electronic product,Equipment,communication equipment,hardware,AC,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),daily necessities,metallic material;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;market survey.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

High quality consumer information automotive dealers can use, not data they have to decipher. Our straightforward delivery of real, actionable and easy to understand lead information, has made significant contributions to the overall sales success of over 4,000 automotive dealers, throughout North America. Specialties Leads Management & Delivery, Leads Consolidation and Standardization, Campaign Marketing, Lead Management Software, CRM, Automotive, Lead Management

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

Founded in 1951 by pharmacists and microbiologists, biose® has 60-year of experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to registration. Focused on health through microbiota and microbiome science, they have specialised skills in the discovery, process development and manufacturing of Live Biotherapeutic Products (LBPs). their company is drug-GMP certified for the manufacturing of bacteria based APIs, clinical products and commercial products.

AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. AVEO's proprietary, integrated cancer biology platform enables the company to pursue highly efficient drug development strategies in oncology that increase the probability of clinical success and provides a discovery engine for high-value targets and therapies. This approach has resulted in a balanced pipeline of novel cancer therapies focused on well-validated targets (VEGFR, EGFR) and promising novel targets (HGF, FGFR, ErbB3 and NOTCH), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals, Schering-Plough, and Biogen Idec. The company was established in 2001 and is based in Cambridge, Massachusetts.